Patent details
EP3380525
Title:
PHARMACEUTICAL FORMULATIONS AND METHODS OF USE THEREOF
Basic Information
- Publication number:
- EP3380525
- PCT Application Number:
- US2016063624
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP168692895
- PCT Publication Number:
- WO2017091745
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL FORMULATIONS AND METHODS OF USE THEREOF
- French Title of Invention:
- FORMULATIONS PHARMACEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
- German Title of Invention:
- PHARMAZEUTISCHE FORMULIERUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON
- SPC Number:
-
Dates
- Filing date:
- 23/11/2016
- Grant date:
- 08/11/2023
- EP Publication Date:
- 03/10/2018
- PCT Publication Date:
- 01/06/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/11/2023
- EP B1 Publication Date:
- 08/11/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 23/11/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/11/2023
-
-
- Name:
- Immunogen, Inc.
- Address:
- 830 Winter Street, Waltham, MA 02451, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 07/12/2023
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
- Name:
- BARTLETT, Elizabeth
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201562260104 P
- Priority Date:
- 25/11/2015
- Priority Country:
- United States (US)
2
- Priority Number:
- 201662368156 P
- Priority Date:
- 28/07/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
C07K 16/46;
C07K 16/28;
C07D 487/04;
Publication
European Patent Bulletin
- Issue number:
- 202345
- Publication date:
- 08/11/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 01/12/2025
- Annual Fee Number:
- 10
- Annual Fee Amount:
- 131 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 11/10/2024
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 115 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)